HBIO
Price
$0.44
Change
-$0.02 (-4.35%)
Updated
Jun 30 closing price
Capitalization
184.01M
36 days until earnings call
NSYS
Price
$8.93
Change
+$0.39 (+4.57%)
Updated
Jun 30 closing price
Capitalization
38.83M
Interact to see
Advertisement

HBIO vs NSYS

Header iconHBIO vs NSYS Comparison
Open Charts HBIO vs NSYSBanner chart's image
Harvard Bioscience
Price$0.44
Change-$0.02 (-4.35%)
Volume$1.67M
Capitalization184.01M
Nortech Systems
Price$8.93
Change+$0.39 (+4.57%)
Volume$39.74K
Capitalization38.83M
HBIO vs NSYS Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NSYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. NSYS commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and NSYS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (HBIO: $0.44 vs. NSYS: $8.93)
Brand notoriety: HBIO and NSYS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HBIO: 10% vs. NSYS: 153%
Market capitalization -- HBIO: $184.01M vs. NSYS: $38.83M
HBIO [@Medical Specialties] is valued at $184.01M. NSYS’s [@Medical Specialties] market capitalization is $38.83M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileNSYS’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • NSYS’s FA Score: 0 green, 5 red.
According to our system of comparison, HBIO is a better buy in the long-term than NSYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 4 TA indicator(s) are bullish while NSYS’s TA Score has 3 bullish TA indicator(s).

  • HBIO’s TA Score: 4 bullish, 5 bearish.
  • NSYS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both HBIO and NSYS are a bad buy in the short-term.

Price Growth

HBIO (@Medical Specialties) experienced а -13.61% price change this week, while NSYS (@Medical Specialties) price change was +6.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.24%. For the same industry, the average monthly price growth was +1.06%, and the average quarterly price growth was +1.33%.

Reported Earning Dates

HBIO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HBIO($184M) has a higher market cap than NSYS($38.8M). NSYS YTD gains are higher at: -13.220 vs. HBIO (-78.967). HBIO (8.03M) and NSYS (8M) have comparable annual earnings (EBITDA) . HBIO has more cash in the bank: 4.28M vs. NSYS (960K). NSYS has less debt than HBIO: NSYS (14.2M) vs HBIO (42.8M). NSYS has higher revenues than HBIO: NSYS (139M) vs HBIO (112M).
HBIONSYSHBIO / NSYS
Capitalization184M38.8M474%
EBITDA8.03M8M100%
Gain YTD-78.967-13.220597%
P/E RatioN/A5.95-
Revenue112M139M81%
Total Cash4.28M960K446%
Total Debt42.8M14.2M301%
FUNDAMENTALS RATINGS
HBIO vs NSYS: Fundamental Ratings
HBIO
NSYS
OUTLOOK RATING
1..100
4926
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
6082
P/E GROWTH RATING
1..100
263
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NSYS's Valuation (52) in the Electronic Components industry is somewhat better than the same rating for HBIO (100) in the Biotechnology industry. This means that NSYS’s stock grew somewhat faster than HBIO’s over the last 12 months.

NSYS's Profit vs Risk Rating (61) in the Electronic Components industry is somewhat better than the same rating for HBIO (100) in the Biotechnology industry. This means that NSYS’s stock grew somewhat faster than HBIO’s over the last 12 months.

NSYS's SMR Rating (93) in the Electronic Components industry is in the same range as HBIO (99) in the Biotechnology industry. This means that NSYS’s stock grew similarly to HBIO’s over the last 12 months.

HBIO's Price Growth Rating (60) in the Biotechnology industry is in the same range as NSYS (82) in the Electronic Components industry. This means that HBIO’s stock grew similarly to NSYS’s over the last 12 months.

HBIO's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for NSYS (63) in the Electronic Components industry. This means that HBIO’s stock grew somewhat faster than NSYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIONSYS
RSI
ODDS (%)
Bearish Trend 5 days ago
60%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 22 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 5 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
72%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NSYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EIHDF0.81N/A
N/A
888 Holdings plc.
MRPRF12.70N/A
N/A
Merlin Properties Socimi SA
MEXGF0.04N/A
N/A
MEXICAN GOLD MNG CORP.
SAXPF10.40N/A
N/A
Sampo OYJ
AWLNF0.32N/A
N/A
AWILCO LNG AS

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-4.27%
IRMD - HBIO
53%
Loosely correlated
-1.73%
SGHT - HBIO
39%
Loosely correlated
-3.95%
A - HBIO
38%
Loosely correlated
-0.97%
ICUI - HBIO
36%
Loosely correlated
+0.25%
NOTV - HBIO
36%
Loosely correlated
+7.06%
More

NSYS and

Correlation & Price change

A.I.dvisor tells us that NSYS and STRR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSYS and STRR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSYS
1D Price
Change %
NSYS100%
+4.25%
STRR - NSYS
29%
Poorly correlated
-0.99%
CATX - NSYS
29%
Poorly correlated
-8.51%
HBIO - NSYS
23%
Poorly correlated
-4.27%
ICUI - NSYS
23%
Poorly correlated
+0.25%
BNGO - NSYS
23%
Poorly correlated
-0.30%
More